Further studies on MMP-2 inhibitors, such as the selective gelatinase inhibitor SB-3CT, revealed a reduction in glioma cell invasion and a decrease in angiogenesis by preventing endothelial cell migration, a critical process in tumor vascularization. The gene discussed is MMP2; the disease is glioma.